Overview
- 128 inspections across 111 sites are on record.
- 603 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-03-27.
At a glance
Inspections
128
Sites
111
Observations
603
Career since
Sep 2010
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Charles River Laboratories, Inc. | 27 Mar 2026 | Human Drugs | On file |
| Societal CDMO Gainesville, LLC | 27 Feb 2026 | Human Drugs | On file |
| RNV LLC | 31 Oct 2025 | Human Drugs | On file |
| Transpire Bio Inc | 1 Oct 2025 | Human Drugs | On file |
| Kappa Laboratories, Inc. | 4 Jun 2025 | Human Drugs | On file |
Sites inspected
Charles River Laboratories, Inc.Charleston, United States1 insp.
Societal CDMO Gainesville, LLCGainesville, United States1 insp.
RNV LLCMiami Lakes, United States1 insp.
Transpire Bio IncWeston, United States1 insp.
Kappa Laboratories, Inc.Miami, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Joanne E King9 shared
Rozelle G Smith6 shared
Dorothy P Kramer4 shared
Kayla V Sprague4 shared
Vivin George4 shared
Richard A Lyght4 shared
Craig A Garmendia4 shared
German Rivera4 shared
Mickell Smith3 shared
Teresa I Navas3 shared
Full investigator report
Get the verbatim findings behind Jennifer Lalama's 603 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site